Search - tctmd.com

Displaying 721 - 740 of 2772

Sort: Relevancy | Date

Presentation THT 2025

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

Presenter: Nir Uriel

February 11, 2025

Presentation Controversies and Advances 2025

Changing ABO Blood Type During Ex Vivo Perfusion

Presenter: Fardad Esmailian

January 31, 2025

Presentation Miami Valves 2025

Percutaneous Stenting of Severe LVAD Outflow Graft Obstruction

Presenter: Nicholas J. Ruggiero II

January 30, 2025

Presentation Miami Valves 2025

Left Atrium to Coronary Sinus Shunting: Edwards’ APTURE shunt and ALT-FLOW II trial status

Presenter: Santiago Garcia

January 30, 2025

Presentation Miami Valves 2025

Recurrent Heart Failure after M-TEER More than the Mitral Valve

Presenter: Christian F. Witzke

January 30, 2025

Presentation Miami Valves 2025

TAVR Failures: Complex Decision Making for Aortic Stenosis Management

Presenter: Jeffrey Popma

January 30, 2025

Presentation AHA 2024

Randomized Study Comparing PK/PD Properties of a Novel Intranasal Formulation of Bumetanide to Oral and IV Formulations

Presenter: Daniel Bensimhon

November 18, 2024

Presentation AHA 2024

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Presenter: Sanjit S Jolly

November 17, 2024

Presentation AHA 2024

Novel AI to Assess Intracardiac Filling Pressure: The Non-invasive SEISMocardiogram In Cardiovascular Monitoring for Heart Failure I (SEISMIC-HF I) Study

Presenter: Liviu Klein

November 16, 2024

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

Presentation TCT 2024

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

Transcatheter VIV (With Appropriate Leaflet Modification) Will Dominate!

Presenter: Adam Greenbaum

October 30, 2024

Presentation TCT 2024

Re-Do Surgery has Clear Long-Term Advantages and is Preferred!

Presenter: Michael Bowdish

October 30, 2024

Presentation TCT 2024

Electrosurgery Leaflet Modification – Technique and Results After BASILICA

Presenter: Jaffar Khan

October 30, 2024

Presentation TCT 2024

Mechanical Leaflet Modification – Technique and Results After SHORTCUT

Presenter: Danny Dvir

October 30, 2024

Presentation TCT 2024

Case: Surgical Bioprosthetic Valve Failure in a 70-year-old

Presenter: Benjamin Galper

October 30, 2024

Presentation TCT 2024

CASE Resolution: Surgical Bioprosthetic Valve Failure in a 70-year-old

Presenter: Benjamin Galper

October 30, 2024

Presentation TCT 2024

The Essentials of CT-Imaging to Plan Transcatheter Valve-in-Valve (VIV) Procedures

Presenter: Philipp Blanke

October 30, 2024

Presentation TCT 2024

Optimizing Hemodynamic Outcomes During VIV Procedures: When and How to Perform Valve Fracture

Presenter: Keith Allen

October 30, 2024

Presentation TCT 2024

How AI Applications Can Change the Landscape of Heart Failure Management

Presenter: Timothy Poterucha

October 30, 2024

Advertisement

Increasing Access: Reducing Referral Delay in Ambulatory Advanced HF Patients

Changing ABO Blood Type During Ex Vivo Perfusion

Percutaneous Stenting of Severe LVAD Outflow Graft Obstruction

Left Atrium to Coronary Sinus Shunting: Edwards’ APTURE shunt and ALT-FLOW II trial status

Recurrent Heart Failure after M-TEER More than the Mitral Valve

TAVR Failures: Complex Decision Making for Aortic Stenosis Management

Randomized Study Comparing PK/PD Properties of a Novel Intranasal Formulation of Bumetanide to Oral and IV Formulations

Routine spironolactone in Acute Myocardial Infarction, results from the CLEAR SYNERGY OASIS 9 trial

Novel AI to Assess Intracardiac Filling Pressure: The Non-invasive SEISMocardiogram In Cardiovascular Monitoring for Heart Failure I (SEISMIC-HF I) Study

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

TCT 870: Prediction Models for the Treatment of Bioprosthetic Aortic Valve Failure in the United States

Transcatheter VIV (With Appropriate Leaflet Modification) Will Dominate!

Re-Do Surgery has Clear Long-Term Advantages and is Preferred!

Electrosurgery Leaflet Modification – Technique and Results After BASILICA

Mechanical Leaflet Modification – Technique and Results After SHORTCUT

Case: Surgical Bioprosthetic Valve Failure in a 70-year-old

CASE Resolution: Surgical Bioprosthetic Valve Failure in a 70-year-old

The Essentials of CT-Imaging to Plan Transcatheter Valve-in-Valve (VIV) Procedures

Optimizing Hemodynamic Outcomes During VIV Procedures: When and How to Perform Valve Fracture

How AI Applications Can Change the Landscape of Heart Failure Management

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content